Cerebrolysin as an adjuvant therapy after mechanical thrombectomy in large vessel occlusion cardioembolic stroke: a propensity score matching analysis.
ElBassiouny A, Shehata MSA, Zaki AS, Bedros RY, El-Sudany AH, Nasser AA · 2025 · Frontiers in neurology. 2025.
Study findings
The study reported 90-day functional independence in 64% of treated patients versus 34.7% of historical controls, alongside fewer hemorrhagic transformations.
- Population and setting
- 75 treated and 75 historical-control patients with cardioembolic stroke after thrombectomy
- Evidence type
- Human comparative study
- Source language
- eng
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Nonrandomized historical comparison; propensity matching does not establish causation.
- Selected cardioembolic stroke population; results cannot be generalized to all stroke patients.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Full-text methods and results check
Source access and review scope
Repository full text checked for design, participants and reported outcomes; no independent reanalysis.
Recorded source-check date: 2026-10-08. This date does not imply a completed systematic review.
Citation and original source
Original source: ElBassiouny A, Shehata MSA, Zaki AS, Bedros RY, El-Sudany AH, Nasser AA. Cerebrolysin as an adjuvant therapy after mechanical thrombectomy in large vessel occlusion cardioembolic stroke: a propensity score matching analysis. Frontiers in neurology. 2025. 2025.
Molekul research summary: https://molekul.io/research/refresh-40027163. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry